ELV (Elevance Health) – Catching the Knife or Catching Value?

66
Elevance (ELV) just took a 12% hit after Q2 earnings missed estimates and full-year guidance was cut significantly. But here's the thing—the selloff may be overdone. The stock now trades at a forward P/E of ~10, well below industry peers, and is approaching multi-year support levels.


📥 Entry Plan :
✅ Entry 1: $302.45 (market price)

✅ Entry 2: $285 (historical support zone)

✅ Entry 3: $250 (capitulation panic level)

🎯 Target Levels:
TP1: $330 – recent gap zone + psychological resistance

TP2: $360 – key horizontal + potential MLR rebound narrative

TP3: $400 – longer-term recovery level, aligns with prior institutional range

🔔 Follow me for more deep-value setups, smart risk-reward trades, and weekly strategy posts!

⚠️ Disclaimer: This content is for informational and educational purposes only and does not constitute financial advice. I am not a financial advisor. Always do your own research and consult with a qualified professional before making any investment decisions. Trading and investing involve risk, including the potential loss of capital

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。